Arvinas logo

BRD4 Degradation by PROTACs® Represents a More Effective Therapeutic Strategy than BRD4 Inhibitors in Ovarian Cancer

Kanak Raina, Ph.D., et al.

April 1, 2016
American Association for Cancer Research 2016
Skip to content